Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. federal law, a Schedule I drug or substance has a high potential for abuse, no accepted medical use in the United States , and a lack of safety for the use of the drug under medical supervision. federal law.

Research and Development 105

Research and Development Clinical Trials Events Treatment 105

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

MARCH 7, 2019

Switzerland’s government will allow 5,000 citizens to use cannabis legally, as part of a country-wide clinical trial. Lawmakers backed scientific studies into the impact of cannabis on public health and safety, ahead of potential regulation, however any rule change is unlikely to occur in the next decade unless fast-tracked.

Clinical Trials 56

Clinical Trials Research and Development Decriminalization Environment 56

Cannabis Law Report

MARCH 2, 2020

The Department of Health and Social Care continues to work closely with NHS England-NHS Improvement (NHSE-I) and the National Institute of Health Research (NIHR) to establish clinical trials to develop the evidence-base to support further commissioning decisions. But we still have a long way to go.

Medicine 59

Medicine Research and Development Clinical Trials Patients 59

Cannabis Law Report

JUNE 4, 2021

It seems completely backwards that an unregulated product that gets people “high” and is synthesized in a lab can be sold at gas stations and smoke shops but naturally derived Delta 9-THC must go through rigorous safety testing and can only be sold and handled by licensed companies.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. The Cannabis Trade Association works to improve and maintain health, safety and environmental regulations and practices around cannabis industries.

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

SEPTEMBER 3, 2019

We are dedicated to making our compliance regimen second-to-none in Australia just as it is in Canada,” said Mr. McCutcheon. Sales generation from the facility is expected to begin in the first half of 2020, subject to receipt of certain local authorizations and a certification from the Therapeutic Goods Association of Australia. “We

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

JUNE 1, 2021

Over the course of her career, she has established, developed, and led several key areas of human resource functions including communications and strategy, talent engagement and management, compliance, and mergers and acquisitions. Sesen Bio remains committed to the health and safety of patients, caregivers and employees.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JULY 21, 2022

Patient safety concerns uncovered during an ongoing federal review have led to the suspension of one of two clinical trials for MDMA-assisted psychotherapy currently underway in Canada. A spokesperson told CBC in an email that the study was put on hold “due to concerns for participant safety.” CBC Canada.

Safety 52

Safety Patients Clinical Trials Data 52

Cannabis Law Report

MARCH 29, 2020

This “zero recall” standard, the team said, was attributed to the fact that their cannabis product standards with regard to food safety and health was high and involved documentation of over 100 pages. . o Respondent checks: Age gates are in place to ensure compliance, and if underaged, then medical licenses must be checked.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

Cannabis Law Report

JULY 24, 2019

321(v), because they are not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling. Office of Compliance. Office of Compliance.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial. medical practitioner), an organisation (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

NOVEMBER 13, 2019

Pharma-grade cannabis is scarce in the world and Denmark has quickly stepped in to fill the niche, cultivating to EU GACP standards, adhering to patient safety, retailing in pharmacies, tracking every medical cannabis prescription, and making patient access affordable. The roadmap ahead includes clinical trials and more research in Denmark.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

OCTOBER 17, 2019

Many of these are meant to address public safety risks, especially for young people. By passing the Cannabis Act, Canada has taken a position of principled non-compliance with its international drug treaty obligations,” says Fraser. alcoholic beverages, caffeine, and tobacco). Court cases also result in changes to the law over time.

Law 40

Law Seed-To-Sale Hemp Recreational 40